| http://www.w3.org/ns/prov#value | - Aradigm set out to sell 50 million of its shares of common stock, at $0.12 per share.Proceeds from the placement will be used to further the development of the medicine, ciprofloxacin, an antibiotic used to treat different types of bacterial infections, frequently experienced by cystic fibrosis patients.Aradigm president and CEO, Igor Gonda, stated in a press release, ???We are very pleased for th
|
